• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: Featured Articles

Featured Articles

Harald Huber

Interview: International Hospital speaks to PENTAX Medical about their new focus on ‘Power of Choice’

, 15 March 2022/in Editors' Picks, Featured Articles /by panglobal
Harald Huber

Harald Huber, Global VP for Product and Category Management at Pentax Medical

International Hospital’s Twan Heesakkers speaks to Harald Huber, Global VP for Product and Category Management at PENTAX Medical, about the company’s new single-use bronchoscope, what they are focusing on this year and the ‘Power of Choice’.

Twan Heesakkers: What new products are you bringing to the market this year?
Harald Huber: This year we will bring a couple of new things to the market. We would like to put more emphasis on the [PENTAX Medical] ONE Pulmo, by creating more public awareness of the product. The ONE Pulmo is a single-use bronchoscope, our first product in the single-use area. We also have the PlasmaTYPHOON+, our unique solution for endoscope drying and storage, which we will also push forward. Furthermore, we are working very hard on providing innovative solutions, instead of following the traditional way the endoscope business was set up, which was more into products and endoscopic processors. We want to bring our way of thinking forward, which is more focussed on developing solutions rather than pure product business. So we want to interconnect these things, for example the PlasmaTYPHOON+ is part of our hygiene commitment. We are calling this the ‘Power of Choice’. This Power of Choice will also apply to our single-use endoscopes and has a compelling advantage for our customers. The idea behind ‘Power of Choice’ is that we do not want to dictate to our customers what kind of procedure they have to do. We want to allow them the highest possible freedom to pick the right equipment for their procedure. That’s why we want to offer as many solutions as possible in different areas and move away from the traditional thinking about products.

The PENTAX Medical ONE Pulmo

The PENTAX Medical ONE Pulmo single-use bronchoscope.

 

TH: You mentioned the single-use bronchoscope – the PENTAX Medical ONE Pulmo for which you received the CE mark last year? Can you tell us a little more about this product; what sets it apart from similar competitors’ products?

HH: When we came up with this solution we thought, ‘if we, as PENTAX Medical, come up with a single-use bronchoscope how will it be different?’ As you know, our company produces reusable products and everybody will ask, why are we coming up with a single-use bronchoscope? And that’s again in line with our idea of providing the Power of Choice. So the difference, I think, to other single-use bronchoscopes that you see on the market is that this is probably the first one that is purely developed by an endoscope company. So, with our expertise in image development we were able to develop a camera in such a way that on one side its  single-use, while on the other side it can provide comparable image quality to our reusable scopes. This is kind of the red line throughout the whole design process and differentiates us from the competition. It also continues with the design of the control body, with the handle actually. We want to provide a real Power of Choice. Doctors should not have to care if they use the single-use scope or the reusable one. They want to have the same familiar touch and feel that they are used to when doing an endoscopy procedure. That’s why we mimic the reusable scope, so it has the same properties of a reusable scope, and we develop it in such a way that it can be offered as a single-use solution.

PENTAX Medical ONE Pulmo

The PENTAX Medical ONE Pulmo is a single-use bronchoscope with superior suction power and HD image quality. The sterile-packed scopes are ready to use. Manoeuvrability and device insertion are easy and intuitive, creating a seamless user experience.

 

TH: Besides offering the ‘Power of Choice’, what other reasons are behind PENTAX Medical choosing to develop a single-use disposable bronchoscope?

HH: ‘Choice’ is an important factor as to why we did this. The other thing is that there is of course concern about contamination. There are special patient populations where it definitely makes sense to go for a single-use scope. We know that it does not make sense for all patient populations. Also, you have the sustainability factor, you have the cost of cleaning, pricing of the product, etc. There are multiple factors which tell you that single-use doesn’t make sense for all patients. However, it makes sense for a certain population – for example patients who are immunocompromised. Imagine somebody who has a very high health risk if somehow cross infected with a germ that is transmitted during the procedure. For this patient do we go with a reusable cope or will we take a single-use scope? And that’s the doctor’s decision, but what we want to make sure  as a provider/manufacturer  that there is little difference in the choice of scope so the same quality of care can be provided to the patient. Because if you do it the other way around and you are a pure single-use provider you cannot offer this choice.

The PENTAX Medical Video Duodenoscopes ED32-i10

The PENTAX Medical Video Duodenoscopes ED32-i10 and ED34-i10T2 combine a sterile disposable elevator cap (DEC™) for single-patient use and simple disposal that advances cleaning capability of the duodenoscope to help reduce the risk of cross-contamination and improve patient care with High-Definition image quality for detailed endoscopic visualization during ERCP procedures.

 

Distal end of the PENTAX Medical Video Duodenoscope ED32-i10

Distal end of the PENTAX Medical Video Duodenoscope ED32-i10

 

TH: PENTAX Medical is leading the collaborative i-scan imaging processing project. Can you explain what this project is about and the purpose of it.

HH: “i-scan is one part of our general solutions approach. For i-scan there are different modalities which support doctors in each step of the diagnostic process. These i-scan modalities include SE – or Surface Enhancing mode – that improves detection, particularly of the shadowed parts of the lesion. There is TE – or Tone Enhancement – which helps in the characterization of the lesion by amplifying the colours so the doctors understand better what they are seeing and can make an informed medical decision. Then we have OE – or Optical Enhancement – an optical filter which helps in demarcation, to understand the actual size of the lesion in the macule that the doctor sees.

This is an example of how we support doctors each step of the way and that’s part of our solution-driven thinking. We are also involved with many physicians for the i-scan project all across Europe and some parts from the US. They add to the project by sharing their insights on how they can benefit from i-scan in their medical procedures. We also use this as part of our learning initiative. Whenever they have tricky images they have identified, they bring them to a forum where they can be discussed.

TH: PENTAX Medical has developed their own data management and software solutions for their medical imaging devices. Can you tell us more about these solutions?

HH: We are deprioritizing data management and hospital software solutions. We are now more focussed on a solutions approach by combining our products and services.

 

TH: PENTAX Medical’s latest image and video processor is the Optivista Plus. I understand it can also be used as an educational platform with its “TwinMode” setting. Can you tell us more about this device?

HH: The TwinMode is an interesting feature! As part of the educational setting, it is possible to show a previously recorded image on the screen so the doctor, or the students in training, can compare these images with the current ones they are seeing. So, for example with the i-scan project, images enhanced with one of the modalities can be compared to the same image without any enhancements. That’s how students learn when they can compare.

 

TH: What else is in the pipeline for PENTAX Medical?
HH:
Our focus is set in the hygiene cosmos, where we have initiatives such as Power of Choice. We also have our World of Intelligence initiative that is focussed on the digital arena, like AI, which supports our solutions-driven approach. We ask the question, what kind of solution can we provide with our different products if you, the customer, combine them together. We have the processors and we have the scopes, we have the single-use scope, we have the semi disposable scopes, we have different image modalities which can be used in different combinations in order to provide the right solution for their particular case. So all that comes together with us being able to provide this choice for doctors.

https://interhospi.com/wp-content/uploads/sites/3/2022/03/harald_huber.jpg 874 1566 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-03-15 13:14:012022-03-17 07:42:47Interview: International Hospital speaks to PENTAX Medical about their new focus on ‘Power of Choice’

International Hospital Federation set to launch Geneva Centre of Healthcare Leadership for Sustainability

, 15 February 2022/in Featured Articles /by panglobal

As the world reflects on the urgent messages of the UN Climate Change Conference (COP26), hospital leaders are increasingly aware of their responsibility to advance the sustainability agenda. Research shows that if the world’s healthcare sector were a country, it would be the fifth-largest emitter of carbon emissions on the planet, according to the The […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/02/Schermafbeelding-2022-02-15-om-10.06.13.png 714 1106 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-02-15 09:11:152022-02-17 10:58:43International Hospital Federation set to launch Geneva Centre of Healthcare Leadership for Sustainability

Pandemic led to stark rise in depressive and anxiety disorders globally in 2020, with women and younger people most affected

, 15 February 2022/in Featured Articles /by panglobal

According to the first global estimates of impacts of the pandemic on mental health, cases of major depressive disorder and anxiety disorders increased by more than a quarter worldwide in 2020 due to the COVID-19 pandemic. International Hospital reports on the research published in The Lancet. [1]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/02/Schermafbeelding-2022-02-15-om-09.56.44.png 816 1554 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-02-15 09:00:062022-02-21 10:25:25Pandemic led to stark rise in depressive and anxiety disorders globally in 2020, with women and younger people most affected

Cash incentives for vaccination could be an effective long-term strategy – here’s how to fund it

, 15 February 2022/in Featured Articles /by panglobal

In many countries, COVID vaccination has been viewed as a race, with the finishing line being double vaccination of a high proportion of the population. Unfortunately, those countries who were initially successful face the challenge of a runner that has reached what they thought was the finishing line being told to run on, as more […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/02/dreamstime_l_223608442-scaled.jpg 1568 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-02-15 08:56:192022-02-15 08:56:19Cash incentives for vaccination could be an effective long-term strategy – here’s how to fund it

New findings for the function of tau in neurodegenerative disease

, 15 February 2022/in Featured Articles /by panglobal

Utilizing cutting-edge proteomics, researchers at the Buck Institute and elsewhere have mapped the “tau interactome” uncovering new findings about the role of tau in neurodegenerative disease. Publishing in Cell, scientists found that mutant tau impacts the function of mitochondria in human neurons. They also suggest a mechanism for how tau gets released from neurons and […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/02/tau-scaled.jpg 2478 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-02-15 08:50:052022-02-21 10:22:02New findings for the function of tau in neurodegenerative disease

Dementia cases set to triple by 2050

, 15 February 2022/in Featured Articles /by panglobal

The Lancet Public Health has published the first comprehensive forecasts for dementia prevalence in 195 countries and territories and examines the impact of expected trends in exposure to four important risk factors – smoking, obesity, high blood sugar, and low education. The forecast shows that dementia cases will rise in every country, with the smallest […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/02/shutterstock_1272573907-scaled.jpg 1707 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-02-15 08:46:422022-02-15 08:47:52Dementia cases set to triple by 2050

Cleveland Clinic launches first-of-its-kind brain study aimed at diagnosing, preventing neurological diseases before symptoms occur

, 15 February 2022/in Featured Articles /by panglobal

Cleveland Clinic has launched a landmark study to better understand why millions of people around the world suffer from brain diseases, with the goal of pinpointing disease biomarkers early, well before clinical symptoms present themselves.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/02/brain_study_1.jpg 1773 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-02-15 08:42:182022-02-15 08:42:18Cleveland Clinic launches first-of-its-kind brain study aimed at diagnosing, preventing neurological diseases before symptoms occur

Overcoming non-adherence: strategies for healthcare professionals

, 15 February 2022/in Featured Articles /by panglobal

In developed countries, adherence among patients suffering chronic diseases averages only 50%, while in developing countries, the rates are even lower. [1]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/02/1.png 909 1097 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-02-15 08:34:242022-02-15 08:37:43Overcoming non-adherence: strategies for healthcare professionals

The first AI breast cancer sleuth that shows its work

, 15 February 2022/in Featured Articles /by panglobal

Computer engineers and radiologists at Duke University have developed an artificial intelligence platform to analyse potentially cancerous lesions in mammography scans to determine if a patient should receive an invasive biopsy. But unlike its many predecessors, this algorithm is interpretable, meaning it shows physicians exactly how it came to its conclusions.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/02/shutterstock_309286820-kopiëren.jpg 1577 1067 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-02-15 08:26:452022-02-15 08:26:45The first AI breast cancer sleuth that shows its work

Hologic’s first global index of women’s health serves as powerful resource for policymakers

, 15 February 2022/in Featured Articles /by panglobal

International Hospital speaks to Tanja Brycker, Vice President, Strategic Development, Breast & Skeletal Health and Gynaecological Surgical Solutions at Hologic, about Hologic’s first Global Women’s Health Index developed from a poll of more than 120,000 women in 116 countries.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2022/02/shutterstock_634637507-kopiëren-scaled.jpg 932 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2022-02-15 08:20:272022-02-15 08:20:27Hologic’s first global index of women’s health serves as powerful resource for policymakers
Page 22 of 102«‹2021222324›»

Latest issue of International Hospital

April 2024

27 June 2025

Scientists launch world first project to create synthetic human genome with £10mn Wellcome funding

27 June 2025

GE HealthCare advances precision imaging with MIM Encore platform

27 June 2025

GE HealthCare advances cardiac PET diagnostics with Flyrcado launch

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription